Gallup finds 11% of US adults currently use GLP-1s for weight loss
Compounded or custom-mixed versions account for 18% of current use, while brand-name products such as Ozempic and Wegovy make up 66%.
MH
By Maren Holt · Senior Reporter, GLP-1
Sep 8 03:00 ETSource: Gallup News
The wire
- 01Gallup's web survey of 5,065 US adults, fielded May 28 to June 5, 2026, found 11% currently using GLP-1s for weight loss, up from 3% in 2024; 15% have ever used.
- 02The 18% compounded share is a direct read on demand facing 503A and 503B pharmacies and telehealth prescribers.
- 03Gallup reports the adult obesity rate at 36.8% in 2026, down from 39.9% in 2022, but figures are self-reported and the estimates were reweighted in September.
From the source
Read at news.gallup.comIn U.S., GLP-1 Usage Reaches New High
Editor’s Note: This story was originally published July 7, 2026, and was updated Sept. 8, 2026, to reflect revised estimates after updating the weighting criteria.